Evidence map›Paper›PMID 34673813›Full record

Trial reportPloS one2021

High association of COVID-19 severity with poor gut health score in Lebanese patients.

Imad Al Kassaa, Sarah El Omari, Nada Abbas, Nicolas Papon, Djamel Drider, Issmat I Kassem, Marwan Osman

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Exact inference around ordinal measures of association is often not exact.Computer methods and programs in biomedicine · 2023
    Article
  5. Article
  6. Journal of biomolecular structure & dynamics · 2023
    Article
  7. COVID-19: Reducing the risk via diet and lifestyle.Journal of integrative medicine · 2023
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Imad Al KassaaFaculty of Public Health, Lebanese University, Beirut, Lebanon.ORCID 0000-0002-2951-2427
Sarah El OmariDepartment of Epidemiology and Population Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.ORCID 0000-0003-3722-9274
Nada AbbasDepartment of Health Management and Policy, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.
Nicolas PaponUniv Angers, Univ Brest, GEIHP, SFR ICAT, Angers, France.
Djamel DriderUMR Transfrontalière BioEcoAgro1158, Univ. Lille, INRAE, Univ. Liège, UPJV, YNCREA, Univ. Artois, Univ. Littoral Côte d'Opale, ICV-Institut Charles Viollette, Lille, France.
Issmat I KassemCenter for Food Safety and Department of Food Science and Technology, University of Georgia, Griffin, GA, United States of America.ORCID 0000-0002-2978-9573
Marwan OsmanDepartment of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States of America.ORCID 0000-0002-6235-2760
American University of Beirut · LBCornell University · USLebanese University · LBUniversité de Bretagne Occidentale · FRUniversité de Lille · FRUniversity of Georgia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) has affected millions of lives globally. However, the disease has presented more extreme challenges for developing countries that are experiencing economic crises. Studies on COVID-19 symptoms and gut health are scarce and have not fully analyzed possible associations between gut health and disease pathophysiology. Therefore, this study aimed to demonstrate a potential association between gut health and COVID-19 severity in the Lebanese community, which has been experiencing a severe economic crisis.

methodsThis cross-sectional study investigated SARS-CoV-2 PCR-positive Lebanese patients. Participants were interviewed and gut health, COVID-19 symptoms, and different metrics were analyzed using simple and multiple logistic regression models.

resultsAnalysis of the data showed that 25% of participants were asymptomatic, while an equal proportion experienced severe symptoms, including dyspnea (22.7%), oxygen need (7.5%), and hospitalization (3.1%). The mean age of the participants was 38.3 ±0.8 years, and the majority were males (63.9%), married (68.2%), and currently employed (66.7%). A negative correlation was found between gut health score and COVID-19 symptoms (Kendall's tau-b = -0.153, P = 0.004); indicating that low gut health was associated with more severe COVID-19 cases. Additionally, participants who reported unhealthy food intake were more likely to experience severe symptoms (Kendall's tau-b = 0.118, P = 0.049). When all items were taken into consideration, multiple ordinal logistic regression models showed a significant association between COVID-19 symptoms and each of the following variables: working status, flu-like illness episodes, and gut health score. COVID-19 severe symptoms were more common among patients having poor gut health scores (OR:1.31, 95%CI:1.07-1.61; P = 0.008), experiencing more than one episode of flu-like illness per year (OR:2.85, 95%CI:1.58-5.15; P = 0.001), and owning a job (OR:2.00, 95%CI:1.1-3.65; P = 0.023).

conclusionsTo our knowledge, this is the first study that showed the impact of gut health and exposure to respiratory viruses on COVID-19 severity in Lebanon. These findings can facilitate combating the pandemic in Lebanon.

Indexed as

PandemicsSARS-CoV-2AdultCOVID-19Cross-Sectional StudiesFemaleHumansIntestinal DiseasesLebanonMaleSeverity of Illness Index

Identifiers

PMID34673813
PMCPMC8530309
OpenAlexW3206138270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.